DOJ’s New Policy Saves $1.65 Million on Transgender Care Now

URGENT UPDATE: The U.S. Department of Justice (DOJ) has just announced a major policy shift that is projected to save taxpayers over $1.65 million previously allocated for transgender medical procedures for federal inmates. This decision, issued on February 19, 2023, marks a significant change in the treatment of transgender individuals within federal prisons.

The new directive states that the federal government will no longer cover expenses for gender-affirming surgeries or related medical treatments for incarcerated individuals identifying as transgender. Previously, the Federal Bureau of Prisons (BOP) was required to fund hormone therapies and surgeries, incurring costs estimated at $1.65 million for taxpayers.

This policy change is expected to generate substantial savings, particularly from surgical requests alone. A DOJ official indicated that the new approach would prevent nearly $2 million from being spent on what they deem “harmful treatments” that raise safety issues within prison facilities.

Under the previous Biden-era policies reinstated in 2022, the BOP had been mandated to follow a comprehensive Transgender Offender Manual, which included provisions for hormone-replacement therapies. In contrast, the revised guidelines from the Trump administration advocate for alternative mental health treatments, such as antidepressants and psychotherapy, instead of surgical interventions for inmates diagnosed with gender dysphoria.

The recent updates terminate taxpayer-funded access to nonmedical items intended for “social transitioning,” including breast padding, chest binders, and other personal items. The policy stipulates that all such accommodations currently in use will be confiscated, although general clothing and cosmetics remain available for purchase within the prison system.

California State Senator Scott Wiener has criticized the policy, describing it as part of a broader “genocidal campaign against trans people.” However, a DOJ official defended the new guidelines, emphasizing the focus on individualized assessments for inmates and highlighting the potential for more effective treatment without resorting to surgeries that may not address underlying psychological issues.

As the DOJ implements these changes, the BOP is expected to redirect funds saved from the policy to support necessary medical treatments for all incarcerated individuals, ensuring a more balanced approach to inmate health care.

This developing story carries significant implications for both the prison system and the ongoing national conversation about transgender rights and health care access. The immediate impact of these changes will be closely monitored as they unfold within federal facilities across the country.

Stay tuned for updates as this situation develops further.